HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 546.32 Thousand USD | -91.08% |
| 2021 | 6.12 Million USD | -31.43% |
| 2020 | 8.93 Million USD | 19.03% |
| 2019 | 7.5 Million USD | -22.43% |
| 2018 | 9.67 Million USD | 226.9% |
| 2017 | 2.96 Million USD | -45.06% |
| 2016 | 5.38 Million USD | -30.82% |
| 2015 | 7.78 Million USD | -25.36% |
| 2014 | 10.43 Million USD | 23554.12% |
| 2013 | 44.12 Thousand USD | -78.5% |
| 2012 | 205.2 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 423.23 Thousand USD | -22.53% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | 4.04 Million USD | -33.97% |
| 2022 FY | 546.32 Thousand USD | -91.08% |
| 2022 Q2 | 2.02 Million USD | -49.99% |
| 2022 Q4 | 546.32 Thousand USD | -71.58% |
| 2022 Q3 | 1.92 Million USD | -4.99% |
| 2021 Q2 | 7.44 Million USD | 5.63% |
| 2021 Q1 | 7.04 Million USD | -21.15% |
| 2021 FY | 6.12 Million USD | -31.43% |
| 2021 Q3 | 7.36 Million USD | -1.05% |
| 2021 Q4 | 6.12 Million USD | -16.8% |
| 2020 Q4 | 8.93 Million USD | -9.15% |
| 2020 Q2 | 11.15 Million USD | 56.22% |
| 2020 Q1 | 7.14 Million USD | -4.86% |
| 2020 FY | 8.93 Million USD | 19.03% |
| 2020 Q3 | 9.83 Million USD | -11.84% |
| 2019 Q1 | 10.15 Million USD | 4.96% |
| 2019 Q4 | 7.5 Million USD | -20.63% |
| 2019 Q2 | 10.15 Million USD | -0.06% |
| 2019 FY | 7.5 Million USD | -22.43% |
| 2019 Q3 | 9.45 Million USD | -6.82% |
| 2018 Q1 | 9.54 Million USD | 222.55% |
| 2018 FY | 9.67 Million USD | 226.9% |
| 2018 Q3 | 9.63 Million USD | 0.45% |
| 2018 Q4 | 9.67 Million USD | 0.43% |
| 2018 Q2 | 9.59 Million USD | 0.47% |
| 2017 Q1 | 3.82 Million USD | -28.99% |
| 2017 FY | 2.96 Million USD | -45.06% |
| 2017 Q4 | 2.96 Million USD | -61.59% |
| 2017 Q3 | 7.7 Million USD | 248.07% |
| 2017 Q2 | 2.21 Million USD | -42.13% |
| 2016 Q1 | 9.78 Million USD | 25.6% |
| 2016 Q2 | 8.36 Million USD | -14.47% |
| 2016 Q3 | 6.9 Million USD | -17.52% |
| 2016 Q4 | 5.38 Million USD | -21.92% |
| 2016 FY | 5.38 Million USD | -30.82% |
| 2015 FY | 7.78 Million USD | -25.36% |
| 2015 Q1 | 10.01 Million USD | -4.04% |
| 2015 Q4 | 7.78 Million USD | -10.86% |
| 2015 Q3 | 8.73 Million USD | -9.62% |
| 2015 Q2 | 9.66 Million USD | -3.45% |
| 2014 Q4 | 10.43 Million USD | -3.34% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 9.05 Million USD | 0.0% |
| 2014 Q3 | 10.79 Million USD | 19.24% |
| 2014 FY | 10.43 Million USD | 23554.12% |
| 2013 Q4 | 44.12 Thousand USD | 0.0% |
| 2013 FY | 44.12 Thousand USD | -78.5% |
| 2012 FY | 205.2 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -9005.4% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 57.895% |
| Biocept, Inc. | 10.37 Million USD | 94.734% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 98.935% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.108% |
| iMD Companies, Inc. | 1.1 Million USD | 50.499% |
| IDenta Corp. | 428.17 Thousand USD | -27.593% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 87.124% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -96.519% |
| NovelStem International Corp. | 3.32 Million USD | 83.567% |
| Optigenex Inc. | 4.42 Million USD | 87.659% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 66.504% |
| Response Genetics, Inc | 4.91 Million USD | 88.891% |
| Rennova Health, Inc. | 359.19 Thousand USD | -52.098% |
| RushNet, Inc. | 4.25 Million USD | 87.153% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -119.363% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 31.576% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 5.215% |
| Todos Medical Ltd. | 33 Million USD | 98.345% |